An international reference reagent for the detection of RHD and SRY DNA in plasma

Vox Sanguinis

Volumn 102, Issue 3, 2012, Pages 243-249

  Metcalfe, P ^a   Rigsby, P ^a   Tait, E ^b   Urbaniak, S ^b  

^a NATIONAL INSTITUTE FOR BIOLOGICAL STANDARDS AND CONTROL   (United Kingdom)

^b UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

Free foetal DNA; Plasma DNA; RHD SRY genotyping

Indexed keywords

REAGENT; RHESUS D ANTIBODY; TESTIS DETERMINING FACTOR;

ADULT; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; DILUTION; DNA SEQUENCE; FEMALE; FREEZE DRYING; GENETIC ANALYSIS; GENOTYPE; GENOTYPING TECHNIQUE; HUMAN; HUMAN TISSUE; MALE; MATERNAL BLOOD; PLASMA; PRIORITY JOURNAL; SENSITIVITY ANALYSIS;

DNA; ERYTHROBLASTOSIS, FETAL; FEMALE; GENOTYPING TECHNIQUES; HUMANS; ISOANTIBODIES; MALE; PLASMA; REFERENCE STANDARDS; RH-HR BLOOD-GROUP SYSTEM; SEX-DETERMINING REGION Y PROTEIN; WORLD HEALTH ORGANIZATION;

EID: 84858298174     PISSN: 00429007     EISSN: 14230410     Source Type: Journal    
DOI: 10.1111/j.1423-0410.2011.01543.x     Document Type: Article

References (16)

1. Wright C: Cell-free fetal nucleic acids for non-invasive prenatal diagnosis - Report of the UK expert working group, 2009. Accessed on 27 September 2011
2. Clausen FB, Christiansen M, Steffensen R, et al.: Report of the first nationally implemented clinical routine screening for fetal RHD in RhD negative pregnant women to ascertain the requirement for antenatal RhD prophylaxis. Transfusion; in press
3. Campbell PJ: International biological standards and reference preparations. II: procedures used for the production of biological standards and reference preparations. J Biol Stand 1974; 2:259-267
4. Finning K, Martin P, Daniels G: A clinical service in the UK to predict fetal Rh (Rhesus) D blood group using free fetal DNA in maternal plasma. Ann N Y Acad Sci 2004; 1022:119-123
5. Finning K, Martin P, Soothill PW, et al.: Prediction of fetal D status from maternal plasma: introduction of a new non-invasive fetal RHD genotyping service. Transfusion 2002; 42:1079-1085
6. Legler T, Liu Z, Mavrou A, et al.: Workshop report on the extraction of foetal DNA from maternal plasma. Prenat Diagn 2007; 27:824-829
7. Lo YM, Magnus Hjelm N, Fidler C, et al.: Prenatal diagnosis of fetal RhD status by molecular analysis of maternal plasma. N Engl J Med 1998; 339:1734-1738
8. Lo YMD, Chiu RWK: Prenatal diagnosis: progress through plasma nucleic acids. Nat Rev Genet 2007; 8:71-77
9. Rouillac-Le Sciellour C, Puillandre P, Gillot R, et al.: Large-scale pre-diagnosis study of fetal RhD genotyping by PCR on plasma DNA from RhD-negative pregnant women. Mol Diagn 2004; 8:23-31
10. Van der Schoot CE, Soussan AA, Koelewijn J, et al.: Noninvasive antenatal RHD typing. Transfus Clin Biol 2006; 13:53-57
11. Finning K, Martin P, Summers J, et al.: Effect of high throughput RhD typing of fetal DNA in maternal plasma on use of anti-RhD immunoglobulin in RhD negative pregnant women: prospective feasibility study. BMJ 2008; 336:816-818
12. Minon JM, Gerard C, Senterre JM, et al.: Routine fetal RhD genotyping with maternal plasma: a four-year experience in Belgium. Transfusion 2008; 48:373-381
13. Müller SP, Bartels I, Stein W, et al.: The determination of the fetal D status from maternal plasma for decision making on Rh prophylaxis is feasible. Transfusion 2008; 48:2292-2301
14. NICE technology appraisal guidance 156, 2008. Routine antenatal anti-D prophylaxis for women who are rhesus D negative. Accessed on 27 September 2011
15. Lun FMF, Chiu RWK, Chan KCA, et al.: Microfluidics digital PCR reveals a higher than expected fraction of fetal DNA in maternal plasma. Clin Chem 2008; 54:1664-1672
16. Chan KCA, Zhang J, Hui ABY, et al.: Size distributions of maternal and fetal DNA in maternal plasma. Clin Chem 2004; 50:188-192